Related Experiment Video

Updated: Aug 7, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Applications of peptide mimetics in cancer

V Apostolopoulos1, J Matsoukas, M Plebanski

  • 1The Scripps Research Institute (BCC206), La Jolla, CA, USA. v.apostolopoulos@ari.unimelb.edu.au

Current Medicinal Chemistry
|April 12, 2002
PubMed

Insights

Cancer vaccines face challenges due to self-antigens. Peptide mimics offer a promising strategy for cancer immunotherapy by potentially eliciting stronger immune responses than self peptides, aiding in human treatments.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Cancer vaccine development is challenging compared to infectious disease vaccines.
  • Tumor antigens often present on normal tissues, hindering strong immune responses against self-antigens.

Purpose of the Study:

  • To review the applications of peptide mimics in cancer immunotherapy.
  • To explore the potential of peptide mimics for human cancer treatment.

Main Methods:

  • Review of existing literature on peptide mimics and cancer immunotherapy.
  • Analysis of immune response mechanisms to peptide mimics versus self-peptides.

Main Results:

  • Peptide mimics may induce stronger immune responses than self-peptides.
  • Potential for peptide mimics to overcome self-antigen tolerance in cancer.

Conclusions:

  • Peptide mimics represent a promising approach for cancer immunotherapy.
  • Further research into peptide mimics could lead to effective human cancer vaccines.

More Related Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Production and Testing of Antimicrobial Peptides and Their Mimics10:35

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.